Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Myron David Kor who wrote (4657)	7/2/1998 8:57:00 PM
From: Linda Kaplan	Read Replies (3) \| Respond to of 7041

Myron: ROFL! You have a vivid imagination. And you're lying, which is such an ugly, ugly thing to do. tsk, tsk, tsk! But, hey, you never were much for accuracy, (you seem to need help to type a sentence), and you must be in serious pain with your ZONA shares worth less than half what they were just a short time ago. So it's hard not to feel sorry for you even if your notes are not nice. I'll do you a favor and will share my thinking with you: I think you should consider selling your remaining ZONA shares now, at over 20, and then should go short. You could try waiting for a pop at the filing in the US, if it ever occurs, or a pop in the stock price at the filing somewhere in Europe, if that ever occurs, but neither pop may amount to much, and after that my guess is that the stock price will be just going down, down and down: into low single digits. Just my guess, but it's the best thinking I can give you. Why? This drug isn't significantly better than a placebo and it's entering a market where there is already an effective (far more effective) and very successful oral drug, which addresses ZONA's population and even a wider population than ZONA. I don't think Vasomax will be approved because it's not effective, but even if it is, I don't think it will make much money because it doesn't work well and because it would be competing with Viagra. If the drug is not approved by the FDA, I should guess that the stock will tank significantly. Those are my honest thoughts and I'm sharing them with you out of kindness. I think you can use some kindness. Unkind people generally haven't had enough kindness in their lives. By the way, you said ZONA was making money in Mexico but you evaded providing any evidence. Can we all spell "HYPE?" Linda